CINF
53
3
TXT
53
-3
SYF
86
-6
CRM
60
-7
MRO
50
4
EXPD
43
-4
ADP
65
-3
NEM
40
3
IBM
47
-3
KMI
69
-2
MAR
63
-5
MCD
52
-5
DLTR
38
-4
STX
45
-4
NWSA
62
-7
STZ
52
-6
TEL
60
-8
YUM
43
-6
DIS
85
3
GLW
45
-3
CINF
53
3
TXT
53
-3
SYF
86
-6
CRM
60
-7
MRO
50
4
EXPD
43
-4
ADP
65
-3
NEM
40
3
IBM
47
-3
KMI
69
-2
MAR
63
-5
MCD
52
-5
DLTR
38
-4
STX
45
-4
NWSA
62
-7
STZ
52
-6
TEL
60
-8
YUM
43
-6
DIS
85
3
GLW
45
-3
Financhill
Back

Goldman Sachs Access US Aggregate Bd ETF Vs. Neurogene Industry Stock Comparison

Sell
42

GCOR
Goldman Sachs Access US Aggregate Bd ETF

Last Price:
40.77
Seasonality Move:
0.4%
Sell
1

NGNE
Neurogene

Last Price:
34.67
Seasonality Move:
50.43%
Sell
42
Goldman Sachs Access US Aggregate Bd ETF (GCOR) is a Sell

Is Goldman Sachs Access US Aggregate Bd ETF a Buy, Sell or Hold?

  • The current Goldman Sachs Access US Aggregate Bd ETF [GCOR] share price is $40.73. The Score for GCOR is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • GCOR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
1
Neurogene (NGNE) is a Sell

Is Neurogene a Buy, Sell or Hold?

  • The current Neurogene [NGNE] share price is $34.52. The Score for NGNE is 1, which is 98% below its historic median score of 50, and infers higher risk than normal.
  • NGNE is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

GCOR Stock Price Chart

What is Goldman Sachs Access US Aggregate Bd ETF's stock price today?

  • The Goldman Sachs Access US Aggregate Bd ETF share price today is $40.73
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GCOR is experiencing slight buying pressure.

NGNE Stock Price Chart

What is Neurogene's stock price today?

  • The Neurogene share price today is $34.52
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NGNE is experiencing selling pressure, which indicates risk of future bearish movement.

GCOR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.24 Sell
Relative Strength Index (14 RSI): 35.55 Sell
Chaikin Money Flow: 12953 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (40.85 - 41.41) Sell
Bollinger Bands (100): (41.02 - 42.24) Sell

NGNE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.55 Sell
Relative Strength Index (14 RSI): 35.74 Sell
Chaikin Money Flow: -452975 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (41.4 - 61.5) Sell
Bollinger Bands (100): (34.32 - 50.52) Sell

GCOR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 40.87 Sell
20-day SMA: 41.02 Sell
50-day SMA: 41.7 Sell
200-day SMA: 41.18 Sell
8-day EMA: 40.86 Sell
20-day EMA: 41.06 Sell
50-day EMA: 41.4 Sell
200-day EMA: 41.32 Sell

NGNE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 53.3 Sell
20-day SMA: 51.47 Sell
50-day SMA: 46.76 Sell
200-day SMA: 38.99 Sell
8-day EMA: 47.13 Sell
20-day EMA: 50.2 Sell
50-day EMA: 47.47 Sell
200-day EMA: 38.44 Sell

Goldman Sachs Access US Aggregate Bd ETF Earnings Growth & GCOR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Neurogene Earnings Growth & NGNE Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.90 per share.

Goldman Sachs Access US Aggregate Bd ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Neurogene Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):